ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

QLGN Qualigen Therapeutics Inc

0.297
-0.0119 (-3.85%)
Last Updated: 10:18:08
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Qualigen Therapeutics Inc QLGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0119 -3.85% 0.297 10:18:08
Open Price Low Price High Price Close Price Prev Close
0.30 0.297 0.319 0.3089
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/16/202407:00GLOBEMarizyme Enters Into Co-Development Agreement With Qualigen..
4/10/202408:00GLOBEQualigen Therapeutics' Novel Direct Pan-RAS Inhibitors..
4/09/202408:00GLOBEQualigen Therapeutics Announces Poster Featuring Positive..
2/27/202407:00EDGAR2Form 8-K - Current report
2/22/202416:10EDGAR2Form 8-K - Current report
12/07/202316:15EDGAR2Form 8-K - Current report
11/22/202316:30EDGAR2Form 8-K - Current report
11/14/202316:30GLOBEQualigen Therapeutics Provides Corporate Update for Third..
11/08/202314:16EDGAR2Form 8-K - Current report
11/07/202308:30GLOBEQualigen Therapeutics Announces First Patient Dosed in the..
10/23/202308:30GLOBEPoster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor..
10/17/202308:30EDGAR2Form 8-K - Current report
9/28/202316:15EDGAR2Form 8-K - Current report
9/27/202308:30GLOBEQualigen Therapeutics Presents Scientific Data on QN-302 at..
9/08/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
9/01/202316:15EDGAR2Form POS AM - Post-Effective amendments for registration..
8/17/202308:30GLOBEQualigen Therapeutics Partners with TD2 for Phase 1 Clinical..
8/15/202310:04EDGAR2Form 8-K - Current report
8/15/202308:30GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..
8/14/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/04/202316:30EDGAR2Form 8-K - Current report
8/01/202308:35EDGAR2Form 8-K - Current report
8/01/202308:30GLOBEQualigen Therapeutics Announces US FDA IND Clearance to..
7/26/202317:25EDGAR2Form 8-K - Current report
7/24/202308:15GLOBEQualigen Therapeutics Divests FastPack® Diagnostics Business
7/13/202317:29EDGAR2Form 8-K - Current report
7/07/202317:08EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
6/05/202308:15GLOBEPoster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor..
5/16/202308:00GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..
5/02/202316:30GLOBEQualigen Therapeutics, Inc. Reports Fourth Quarter and..
5/02/202308:15GLOBEQualigen Therapeutics’ Pan-RAS Inhibitor Program Highlighted..

Your Recent History

Delayed Upgrade Clock